Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiotherapy (IMRT) for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) in the Era of Immune Checkpoint Inhibitor (ICI) Consolidation: A Retrospective Cohort Study

M. Iocolano,N. Yegya-Raman,X. Wang,C. Friedes,S. H. Lee,L. Duan, B. Li,W. P. Levin,K. A. Cengel,C. Langer,R. Cohen,L. Sun,C. Aggarwal,A. Doucette,Y. Xiao,K. Teo,S. E. O'Reilly, W. Zou,C. B. Simone,S. J. Feigenberg

International journal of radiation oncology, biology, physics（2023）

Cited 0|Views11

No score

Abstract

Among pts with LA-NSCLC treated with cCRT in the era of ICI consolidation, PBT was associated with fewer acute unplanned hospitalizations compared to IMRT. There was no difference in G3+ pneumonitis, G3+ esophagitis, PFS or OS.

Translated text

Key words

proton beam therapy,immune checkpoint inhibitor,radiotherapy,cancer,intensity-modulated,non-small,la-nsclc

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined